BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30074324)

  • 1. Polymorphisms of p53 promoter and susceptibility to uterine leiomyoma.
    Ziaei E; Chaleshtori MH; Ziaei A; Dehkordi GB; Pooryamofrad A; Kashani S; Batenipoor M; Miraj S
    Clin Exp Obstet Gynecol; 2016; 43(5):713-717. PubMed ID: 30074324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas.
    Hsieh YY; Chang CC; Tsai FJ; Lin CC; Yeh LS; Tsai CH
    Fertil Steril; 2004 Oct; 82 Suppl 3():1177-81. PubMed ID: 15474092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
    Hsieh YY; Wang JP; Lin CS
    Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
    Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
    Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T allele for VEGF-460 gene polymorphism at 5'-untranslated region is associated with higher susceptibility of leiomyoma.
    Hsieh YY; Chang CC; Tsai FJ; Lin CC; Tsai CH
    Biochem Genet; 2008 Jun; 46(5-6):356-61. PubMed ID: 18256925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas.
    Hsieh YY; Chang CC; Tsai FJ; Lin CC; Tsai CH
    Fertil Steril; 2005 Mar; 83(3):796-9. PubMed ID: 15749523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
    J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
    El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
    Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene.
    Pietrowski D; Thewes R; Sator M; Denschlag D; Keck C; Tempfer C
    Am J Reprod Immunol; 2009 Aug; 62(2):112-7. PubMed ID: 19614627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
    Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
    Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Tsujino T; Ohara N; Yoshida S; Kennedy S; Takemura N; Deguchi M; Maruo T
    Gynecol Endocrinol; 2006 Feb; 22(2):87-91. PubMed ID: 16603433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women.
    Salimi S; Hajizadeh A; Yaghmaei M; Rezaie S; Shahrakypour M; Teimoori B; Parache M; Naghavi A; Mokhtari M
    Tumour Biol; 2016 Sep; 37(9):12497-12502. PubMed ID: 27337955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.
    Kasap B; Öztürk Turhan N; Edgünlü T; Duran M; Akbaba E; Öner G
    Bosn J Basic Med Sci; 2016 Jan; 16(1):39-45. PubMed ID: 26773178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women.
    Vieira LC; Gomes MT; Castro Rde A; de Souza NC; da Silva ID; Baracat EC; Girão MJ
    Gynecol Endocrinol; 2008 Jul; 24(7):373-7. PubMed ID: 18645709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -2549 insertion/deletion polymorphism of VEGF gene associated with uterine leiomyoma susceptibility in women from Southeastern Iran.
    Keshavarzi F; Salimi S; Mohammadpour-Gharehbagh A; Teimoori B; Yazdi A; Farajian-Mashhadi F; Yaghmaei M; Mokhtari M
    Ginekol Pol; 2017; 88(3):115-119. PubMed ID: 28397198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray repair cross-complementing group 4 (XRCC4) promoter -1394( *)T-related genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma.
    Hsieh YY; Chang CC; Bau DT; Yeh LS; Tsai FJ; Tsai CH
    Fertil Steril; 2008 Oct; 90(4 Suppl):1417-23. PubMed ID: 18177646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
    Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
    DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent association of MDM2 promoter polymorphisms and uterine leiomyoma in South-East Iran: A preliminary report.
    Salimi S; Hajizadeh A; Khodamian M; Pejman A; Fazeli K; Yaghmaei M
    J Obstet Gynaecol Res; 2015 May; 41(5):729-34. PubMed ID: 25511444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
    Hsieh YY; Chang CC; Wang YK; Hsu KH; Chen CP; Hsu CM; Tsai FJ
    Anticancer Res; 2010 Jun; 30(6):2203-8. PubMed ID: 20651370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q192R variant in paraoxonase 1 gene confers susceptibility to leiomyoma.
    Shahbazi S; Zarei S; Torfeh M; Fatahi N
    J Cancer Res Ther; 2020; 16(4):884-887. PubMed ID: 32930135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.